You are here:

Home
NICE Guidance
Conditions and diseases
Cancer
Metastases

Enzalutamide for metastatic hormone‑relapsed prostate cancer previously treated with a docetaxel‑containing regimen

Technology appraisal guidance
Reference number: TA316
Published: 23 July 2014

Guidance
Tools and resources
Information for the public
Evidence
History

Royal College of Physicians

Royal College of Physicians: appeals received
Royal College of Physicians: initial scrutiny letter
Royal College of Physicians: response to scrutiny letter
Royal College of Physicians: final scrutiny letter

This page was last updated: 22 July 2014